Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
Nektar Therapeutics
AIDS Malignancy Consortium
National Cancer Institute (NCI)
University of California, Davis
University of Washington
Case Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)